Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer
Open Access
- 1 June 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 35 (10), 1302-1313
- https://doi.org/10.1038/onc.2015.189
Abstract
Acquired therapeutic resistance is the major drawback to effective systemic therapies for cancers. Aggressive triple-negative breast cancers (TNBC) develop resistance to chemotherapies rapidly, whereas the underlying mechanisms are not completely understood. Here we show that genotoxic treatments significantly increased the expression of miR-181a in TNBC cells, which enhanced TNBC cell survival and metastasis upon Doxorubicin treatment. Consistently, high miR-181a level associated with poor disease free survival and overall survival after treatments in breast cancer patients. The upregulation of miR-181a was orchestrated by transcription factor STAT3 whose activation depended on NF-κB-mediated IL-6 induction in TNBC cells upon genotoxic treatment. Intriguingly, activated STAT3 not only directly bound to MIR181A1 promoter to drive transcription but also facilitated the recruitment of MSK1 to the same region where MSK1 promoted a local active chromatin state by phosphorylating histone H3. We further identified BAX as a direct functional target of miR-181a, whose suppression decreased apoptosis and increased invasion of TNBC cells upon Dox treatment. These results were further confirmed by evidence that suppression of miR-181a significantly enhanced therapeutic response and reduced lung metastasis in a TNBC orthotopic model. Collectively, our data suggested that miR-181a induction had a critical role in promoting therapeutic resistance and aggressive behavior of TNBC cells upon genotoxic treatment. Antagonizing miR-181a may serve as a promising strategy to sensitize TNBC cells to chemotherapy and mitigate metastasis.Keywords
This publication has 49 references indexed in Scilit:
- Akirin specifies NF ‐κB selectivity of Drosophila innate immune response via chromatin remodelingThe EMBO Journal, 2014
- H3S28 phosphorylation is a hallmark of the transcriptional response to cellular stressGenome Research, 2014
- Akirin2 is critical for inducing inflammatory genes by bridging IκB‐ζ and the SWI / SNF complexThe EMBO Journal, 2014
- MicroRNAs as therapeutic targets in chemoresistanceDrug Resistance Updates, 2013
- miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAsBreast Cancer Research, 2013
- Many faces of NF-κB signaling induced by genotoxic stressJournal of Molecular Medicine, 2007
- A microRNA component of the p53 tumour suppressor networkNature, 2007
- The colorectal microRNAomeProceedings of the National Academy of Sciences of the United States of America, 2006
- Genes that mediate breast cancer metastasis to lungNature, 2005
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004